Lineage Cell Therapeutics, Inc.

AMEX:LCTX

Biotechnology

Healthcare
$0.84 -2.80%

-$0.04 today

Market cap
$212.10M
Beta
1.51
P/E (TTM)
-4.6
EPS (TTM)
-$0.26
52W Low $0.85High $2.09

Volume 1.22M

Average 1.19M

Price history

Lineage Cell Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-52.63%

Period high

$1.96

Period low

$0.80

Latest

$0.84

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
10-QAug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
SC 13GJul 29, 2026Jul 29, 2026
4Jul 2, 2026Jul 2, 2026
4Jul 2, 2026Jul 2, 2026
4Jul 2, 2026Jul 2, 2026
4Jul 2, 2026Jul 2, 2026
4Jul 2, 2026Jul 2, 2026
4Jul 2, 2026Jul 2, 2026
8-KJun 12, 2026Jun 12, 2026
8-KMay 12, 2026May 12, 2026
10-QMay 12, 2026May 12, 2026
DEFA14AApr 29, 2026Apr 29, 2026

Competitors

Who does Lineage Cell Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about LCTX's filings, answered from its disclosures.

What is the latest LCTX filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does LCTX have?

Intrinsic Alpha currently shows 20 recent filings for LCTX.